Anti-amyloidogenic properties of some phenolic compounds

Biomolecules

Volumn 5, Issue 2, 2015, Pages 505-527

  Porzoor, Afsaneh ^a   Alford, Benjamin ^a   Hügel, Helmut M ^a   Grando, Danilla ^a   Caine, Joanne ^b   Macreadie, Ian ^a  

^a RMIT UNIVERSITY   (Australia)

^b CSIRO   (Australia)

Author keywords

AHP1; Alzheimer s disease; Anti amyloidogenic; Danshen; Polyphenols; Saccharomyces cerevisiae

Indexed keywords

2, 3 DIHYDROXYBENZOIC ACID; 2,4 DIHYDROXYCINNAMIC ACID; 2,4,5 TRIMETHOXY CINNAMIC ACID; AMYLOID BETA PROTEIN [1-42]; BENZOFURAN DERIVATIVE; CAFFEIC ACID; CHALCONE; EPIGALLOCATECHIN GALLATE; FERULIC ACID; GALLIC ACID; GENTISIC ACID; GREEN FLUORESCENT PROTEIN; HEXAFLUORO 2 PROPANOL; HYDROXYL GROUP; OLIGOMER; PHENOL DERIVATIVE; POLYPHENOL DERIVATIVE; PROTEIN INHIBITOR; PROTOCATECHUIC ACID; ROSMARINIC ACID; SALVIANOLIC ACID B; THIOFLAVINE; UNCLASSIFIED DRUG; AHP1 PROTEIN, S CEREVISIAE; AMYLOID; AMYLOID BETA PROTEIN; AMYLOID BETA-PROTEIN (2-42); MOLECULAR LIBRARY; PEPTIDE FRAGMENT; PEROXIREDOXIN; PLANT EXTRACT; POLYPHENOL;

ALZHEIMER DISEASE; ANTI AMYLOIDOGENIC ACTIVITY; ARTICLE; CANDIDA GLABRATA; CELL DEATH; CHEMICAL STRUCTURE; CONTROLLED STUDY; CYTOTOXICITY ASSAY; DRUG ACTIVITY; FIBER; FLOW CYTOMETRY; FLUORESCENCE ANALYSIS; GENETIC TRANSFORMATION; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN AGGREGATION; PROTEIN DEGRADATION; PROTEIN SYNTHESIS INHIBITION; SACCHAROMYCES CEREVISIAE; SALVIA MILTIORRHIZA; SILVER STAINING; SYNTHESIS; TRANSMISSION ELECTRON MICROSCOPY; WESTERN BLOTTING; YEAST CELL; CHEMISTRY; DRUG EFFECTS; GENETICS; METABOLISM; MOLECULAR LIBRARY; PHARMACOLOGY;

SACCHAROMYCES CEREVISIAE;

AMYLOID; AMYLOID BETA-PEPTIDES; PEPTIDE FRAGMENTS; PEROXIREDOXINS; PLANT EXTRACTS; POLYPHENOLS; SACCHAROMYCES CEREVISIAE; SALVIA MILTIORRHIZA; SMALL MOLECULE LIBRARIES;

EID: 85012066724     PISSN: None     EISSN: 2218273X     Source Type: Journal    
DOI: 10.3390/biom5020505     Document Type: Article

References (86)

1. Glabe, C.G. Structural classification of toxic amyloid oligomers. J. Biol. Chem. 2008, 283, 29639-29643.
2. Klyubin, I.; Cullen, W.K.; Hu, N.W.; Rowan, M.J. Alzheimer's disease Aβ assemblies mediating rapid disruption of synaptic plasticity and memory. Mol. Brain 2012, doi:10.1186/1756-6606-5-25.
3. Jin, M.; Shepardson, N.; Yang, T.; Chen, G.; Walsh, D.; Selkoe, D.J. Soluble amyloid beta-protein dimers isolated from Alzheimer cortex directly induce Tau hyperphosphorylation and neuritic degeneration. Proc. Natl. Acad. Sci. USA 2011, 108, 5819-5824.
4. Lacor, P.N.; Buniel, M.C.; Chang, L.; Fernandez, S.J.; Gong, Y.; Viola, K.L.; Lambert, M.P.; Velasco, P.T.; Bigio, E.H.; Finch, C.E.; et al. Synaptic targeting by Alzheimer's-related amyloid beta oligomers. J. Neurosci. 2004, 24, 10191-10200.
5. Lambert, M.P.; Barlow, A.K.; Chromy, B.A.; Edwards, C.; Freed, R.; Liosatos, M.; Morgan, T.E.; Rozovsky, I.; Trommer, B.; Viola, K.L. ; et al. Diffusible, nonfibrillar ligands derived from Aβ 1-42 are potent central nervous system neurotoxins. Proc. Natl. Acad. Sci. USA 1998, 95, 6448-6453.
6. Wu, H.Y.; Hudry, E.; Hashimoto, T.; Kuchibhotla, K.; Rozkalne, A.; Fan, Z.; Spires-Jones, T.; Xie, H.; Arbel-Ornath, M.; Grosskreutz, C.L.; et al. Amyloid β induces the morphological neurodegenerative triad of spine loss, dendritic simplification, and neuritic dystrophies through calcineurin activation. J. Neurosci. 2010, 30, 2636-2649.
7. Matharu, B.; El-Agnaf, O.; Razvi, A.; Austen, B.M. Development of retro-inverso peptides as anti-aggregation drugs for β-amyloid in Alzheimer's disease. Peptides 2010, 31, 1866-1872.
8. H�rd, T.; Lendel, C. Inhibition of amyloid formation. J. Mol. Biol. 2012, 421, 441-465.
9. Keshet, B.; Good, T. Aβ toxicity inhibitors as probes of Aβ "active-site". Alzheimers Dement. 2010, doi:10.1016/j.jalz.2010.05.806.
10. Cheng, B.; Gong, H.; Xiao, H.; Petersen, R.B.; Zheng, L.; Huang, K. Inhibiting toxic aggregation of amyloidogenic proteins: A therapeutic strategy for protein misfolding diseases. Biochim. Biophys. Acta 2013, 1830, 4860-4871.
11. Harvey, B.S.; Musgrave, I.F.; Ohlsson, K.S.; Fransson, Å.; Smid, S.D. The green tea polyphenol (_)-epigallocatechin-3-gallate inhibits amyloid-β evoked fibril formation and neuronal cell death in vitro. Food Chem. 2011, 129, 1729-1736.
12. Ono, K.; Yoshiike, Y.; Takashima, A.; Hasegawa, K.; Naiki, H.; Yamada, M. Potent anti-amyloidogenic and fibril-destabilizing effects of polyphenols in vitro : Implications for the prevention and therapeutics of Alzheimer's disease. J. Neurochem. 2003, 87, 172-181.
13. Pallauf, K.; Rimbach, G. Autophagy, polyphenols and healthy ageing. Ageing Res. Rev. 2013, 12, 237-252.
14. Qin, R.A.; Yao, X.X.; Huang, Z.Y. Effects of compound danshen tablets on spatial cognition and expression of brain beta-amyloid precursor protein in a rat model of Alzheimer's disease. J. Tradit. Chin. Med. 2012, 32, 63-66.
15. Mandel, S.; Amit, T.; Reznichenko, L.; Weinreb, O.; Youdim, M.B. Green tea catechins as brain-permeable, natural iron chelators-antioxidants for the treatment of neurodegenerative disorders. Mol. Nutr. Food Res. 2006, 50, 229-234.
16. Maurya, P.K.; Rizvi, S.I. Protective role of tea catechins on erythrocytes subjected to oxidative stress during human aging. Nat. Prod. Res. 2009, 23, 1072-1079.
17. Nichols, J.A.; Katiyar, S.K. Skin photoprotection by natural polyphenols: Anti-inflammatory, antioxidant and DNA repair mechanisms. Arch. Dermatol. Res. 2010, 302, 71-83.
18. Qin, X.-Y.; Cheng, Y.; Yu, L.-C. Potential protection of green tea polyphenols against intracellular amyloid β-induced toxicity on primary cultured prefrontal cortical neurons of rats. Neurosci. Lett. 2012, 513, 170-173.
19. Rezai-Zadeh, K.; Shytle, D.; Sun, N.; Mori, T.; Hou, H.; Jeanniton, D.; Ehrhart, J.; Townsend, K.; Zeng, J.; Morgan, D.; et al. Green tea epigallocatechin-3-gallate (EGCG) modulates amyloid precursor protein cleavage and reduces cerebral amyloidosis in Alzheimer transgenic mice. J. Neurosci. 2005, 25, 8807-8814.
20. Lee, J.W.; Lee, Y.K.; Ban, J.O.; Ha, T.Y.; Yun, Y.P.; Han, S.B.; Oh, K.W.; Hong, J.T. Green tea (_)-epigallocatechin-3-gallate inhibits β-amyloid-induced cognitive dysfunction through modification of secretase activity via inhibition of ERK and NF-κB pathways in mice. J. Nutr. 2009, 139, 1987-1993.
21. Cox, C.J.; Choudhry, F.; Peacey, E.; Perkinton, M.S.; Richardson, J.C.; Howlett, D.R.; Lichtenthaler, S.F.; Francis, P.T.; Williams, R.J. Dietary (_)-epicatechin as a potent inhibitor of βγ-secretase amyloid precursor protein processing. Neurobiol. Aging 2015, 36, 178-187.
22. Palhano, F.L.; Lee, J.; Grimster, N.P.; Kelly, J.W. Toward the molecular mechanism(s) by which EGCG treatment remodels mature amyloid fibrils. J. Am. Chem. Soc. 2013, 135, 7503-7510.
23. Wu, A.; Ying, Z.; Gomez-Pinilla, F. Dietary curcumin counteracts the outcome of traumatic brain injury on oxidative stress, synaptic plasticity, and cognition. Exp. Neurol. 2006, 197, 309-317.
24. L�thi, U.; Schaerer-Brodbeck, C.; Tanner, S.; Middendorp, O.; Edler, K.; Barberis, A. Human β-secretase activity in yeast detected by a novel cellular growth selection system. Biochim. Biophys. Acta 2003, 1620, 167-178.
25. Edbauer, D.; Winkler, E.; Regula, J.T.; Pesold, B.; Steiner, H.; Haass, C. Reconstitution of β-secretase activity. Nat. Cell Biol. 2003, 5, 486-488.
26. Eskelinen, E.-L.; Saftig, P. Autophagy: A lysosomal degradation pathway with a central role in health and disease. Biochim. Biophys. Acta 2009, 1793, 664-673.
27. P�rez-Areales, F.J.; di Pietro, O.; Espargar�, A.; Vallverd�-Queralt, A.; Galdeano, C.; Ragusa, I.M.; Viayna, E.; Guillou, C.; Clos, M.V.; Perez, B.; et al. Shogaol-huprine hybrids: Dual antioxidant and anticholinesterase agents with β-amyloid and tau anti-aggregating properties. Bioorg. Med. Chem. Lett. 2014, 22, 5298-5307.
28. H�gel, H.M.; Jackson, N. Danshen diversity defeating dementia. Bioorg. Med. Chem. Lett. 2014, 24, 708-716.
29. Teixeira, J.; Gaspar, A.; Garrido, E.M.; Garrido, J.; Borges, F. Hydroxycinnamic acid antioxidants: An electrochemical overview. Biomed. Res. Int. 2013, doi:10.1155/2013/251754.
30. Wang, X.; Morris-Natschke, S.L.; Lee, K.-H. New developments in the chemistry and biology of the bioactive constituents of Tanshen. Med. Res. Rev. 2007, 27, 133-148.
31. Feng, Y.; You, Z.; Yan, S.; He, G.; Chen, Y.; Gou, X.; Peng, C. Antidepressant-like effects of salvianolic acid B in the mouse forced swim and tail suspension tests. Life Sci. 2012, 90, 1010-1014.
32. Kim, D.H.; Park, S.J.; Kim, J.M.; Jeon, S.J.; Kim, D.H.; Cho, Y.W.; Son, K.H.; Lee, H.J.; Moon, J.H.; Cheong, J.H.; et al. Cognitive dysfunctions induced by a cholinergic blockade and Aβ25-35 peptide are attenuated by salvianolic acid B. Neuropharmacology 2011, 61, 1432-1440.
33. Lee, Y.W.; Kim, D.H.; Jeon, S.J.; Park, S.J.; Kim, J.M.; Jung, J.M.; Lee, H.E.; Bae, S.G.; Oh, H.K.; Son, K.H.; et al. Neuroprotective effects of salvianolic acid B on an Aβ25-35 peptide-induced mouse model of Alzheimer's disease. Eur. J. Pharmacol. 2013, 704, 70-77.
34. Shi, L.-L.; Yang, W.-N.; Chen, X.-L.; Zhang, J.-S.; Yang, P.-B.; Hu, X.-D.; Han, H.; Qian, Y.-H.; Liu, Y. The protective effects of tanshinone IIA on neurotoxicity induced by β-amyloid protein through calpain and the p35/Cdk5 pathway in primary cortical neurons. Neurochem. Int. 2012, 61, 227-235.
35. Tian, L.L.; Wang, X.J.; Sun, Y.N.; Li, C.R.; Xing, Y.L.; Zhao, H.B.; Duan, M.; Zhou, Z.; Wang, S.Q. Salvianolic acid B, an antioxidant from salvia miltiorrhiza, prevents 6-hydroxydopamine induced apoptosis in SH-SY5Y cells. Int. J. Biochem. Cell Biol. 2008, 40, 409-422.
36. Yu, H.; Yao, L.; Zhou, H.; Qu, S.; Zeng, X.; Zhou, D.; Zhou, Y.; Li, X.; Liu, Z. Neuroprotection against Aβ25-35-induced apoptosis by salvia miltiorrhiza extract in SH-SY5Y cells. Neurochem. Int. 2014, 75, 89-95.
37. Zhou, Y.; Li, W.; Xu, L.; Chen, L. In salvia miltiorrhiza, phenolic acids possess protective properties against amyloid β-induced cytotoxicity, and tanshinones act as acetylcholinesterase inhibitors. Environ. Toxicol. Pharmacol. 2011, 31, 443-452.
38. Hudson, S.A.; Ecroyd, H.; Kee, T.W.; Carver, J.A. The thioflavin T fluorescence assay for amyloid fibril detection can be biased by the presence of exogenous compounds. FEBS J. 2009, 276, 5960-5972.
39. Rizzo, S.; Rivi�re, C.; Piazzi, L.; Bisi, A.; Gobbi, S.; Bartolini, M.; Andrisano, V.; Morroni, F.; Tarozzi, A.; Monti, J.-P.; et al. Benzofuran-based hybrid compounds for the inhibition of cholinesterase activity, β amyloid aggregation, and Aβ neurotoxicity. J. Med. Chem. 2008, 51, 2883-2886.
40. Choi, H.-D.; Seo, P.-J.; Son, B.-W.; Kang, B.-W. Synthesis of 5-chloro-3-[4-(3-diethylaminopropoxy)benzoyl]-2-(4-methoxyphenyl)benzofuran as a β-amyloid aggregation inhibitor. Arch. Pharm. Res. 2003, 26, 985-989.
41. Bramanti, E.; Fulgentini, L.; Bizzarri, R.; Lenci, F.; Sgarbossa, A. β-amyloid amorphous aggregates induced by the small natural molecule ferulic acid. J. Phys. Chem. B 2013, 117, 13816-13821.
42. Levy-Sakin, M.; Shreberk, M.; Daniel, Y.; Gazit, E. Targeting insulin amyloid assembly by small aromatic molecules: Toward rational design of aggregation inhibitors. Islets 2009, 1, 210-215.
43. Gazit, E. A possible role for PI-stacking in the self-assembly of amyloid fibrils. FASEB J. 2002, 16, 77-83.
44. Tartaglia, G.G.; Cavalli, A.; Pellarin, R.; Caflisch, A. The role of aromaticity, exposed surface, and dipole moment in determining protein aggregation rates. Protein Sci. 2004, 13, 1939-1941.
45. Ono, K.; Hamaguchi, T.; Naiki, H.; Yamada, M. Anti-amyloidogenic effects of antioxidants: Implications for the prevention and therapeutics of Alzheimer's disease. Biochim. Biophys. Acta 2006, 1762, 575-586.
46. Jayamani, J.; Shanmugam, G. Gallic acid, one of the components in many plant tissues, is a potential inhibitor for insulin amyloid fibril formation. Eur. J. Med. Chem. 2014, 85, 352-358.
47. LeVine, H., 3rd; Lampe, L.; Abdelmoti, L.; Augelli-Szafran, C.E. Dihydroxybenzoic acid isomers differentially dissociate soluble biotinyl-Aβ(1-42) oligomers. Biochemistry 2012, 51, 307-315.
48. Hawkes, C.A.; Deng, L.-H.; Shaw, J.E.; Nitz, M.; McLaurin, J. Small molecule β-amyloid inhibitors that stabilize protofibrillar structures in vitro improve cognition and pathology in a mouse model of alzheimer's disease. Eur. J. Neurosci. 2010, 31, 203-213.
49. Ehrnhoefer, D.E.; Bieschke, J.; Boeddrich, A.; Herbst, M.; Masino, L.; Lurz, R.; Engemann, S.; Pastore, A.; Wanker, E.E. EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomers. Nat. Struct. Mol. Biol. 2008, 15, 558-566.
50. Kim, W.; Kim, Y.; Min, J.; Kim, D.J.; Chang, Y.T.; Hecht, M.H. A high-throughput screen for compounds that inhibit aggregation of the Alzheimer's peptide. ACS Chem. Biol. 2006, 1, 461-469.
51. Caine, J.; Sankovich, S.; Antony, H.; Waddington, L.; Macreadie, P.; Varghese, J.; Macreadie, I. Alzheimer's Aβ fused to green fluorescent protein induces growth stress and a heat shock response. FEMS Yeast Res. 2007, 7, 1230-1236.
52. Wurth, C.; Guimard, N.K.; Hecht, M.H. Mutations that reduce aggregation of the Alzheimer's Aβ42 peptide: An unbiased search for the sequence determinants of Aβ amyloidogenesis. J. Mol. Biol. 2002, 319, 1279-1290.
53. Iwai, K.; Naganuma, A.; Kuge, S. Peroxiredoxin Ahp1 acts as a receptor for alkylhydroperoxides to induce disulfide bond formation in the Cad1 transcription factor. J. Biol. Chem. 2010, 285, 10597-10604.
54. Lian, F.M.; Yu, J.; Ma, X.X.; Yu, X.J.; Chen, Y.; Zhou, C.Z. Structural snapshots of yeast alkyl hydroperoxide reductase Ahp1 peroxiredoxin reveal a novel two-cysteine mechanism of electron transfer to eliminate reactive oxygen species. J. Biol. Chem. 2012, 287, 17077-17087.
55. Bharadwaj, P.R.; Verdile, G.; Barr, R.K.; Gupta, V.; Steele, J.W.; Lachenmayer, M.L.; Yue, Z.; Ehrlich, M.E.; Petsko, G.; Ju, S. ; et al. Latrepirdine (dimebon) enhances autophagy and reduces intracellular GFP-Aβ42 levels in yeast. J. Alzheimers Dis. 2012, 32, 949-967.
56. Porzoor, A.; Caine, J.M.; Macreadie, I.G. Pretreatment of chemically-synthesized Aβ42 affects its biological activity in yeast. Prion 2014, 8, 404-410.
57. Walsh, D.M.; Townsend, M.; Podlisny, M.B.; Shankar, G.M.; Fadeeva, J.V.; el Agnaf, O.; Hartley, D.M.; Selkoe, D.J. Certain inhibitors of synthetic amyloid β-peptide (Aβ) fibrillogenesis block oligomerization of natural Aβ and thereby rescue long-term potentiation. J. Neurosci. 2005, 25, 2455-2462.
58. Wang, Q.; Walsh, D.M.; Rowan, M.J.; Selkoe, D.J.; Anwy, L.R. Block of long-term potentiation by naturally secreted and synthetic amyloid β-peptide in hippocampal slices is mediated via activation of the kinases c-Jun N-terminal kinase, cyclin-dependent kinase 5, and p38 mitogen-activated protein kinase as well as metabotropic glutamate receptor type 5. J. Neurosci. 2004, 24, 3370-3378.
59. Blanchard, B.J.; Chen, A.; Rozeboom, L.M.; Stafford, K.A.; Weigele, P.; Ingram, V.M. Efficient reversal of Alzheimer's disease fibril formation and elimination of neurotoxicity by a small molecule. Proc. Natl. Acad. Sci. USA 2004, 101, 14326-14332.
60. De Felice, F.G.; Vieira, M.N.; Saraiva, L.M.; Figueroa-Villar, J.D.; Garcia-Abreu, J.; Liu, R.; Chang, L.; Klein, W.L.; Ferreira, S.T. Targeting the neurotoxic species in Alzheimer's disease: Inhibitors of Aβ oligomerization. FASEB J. 2004, 18, 1366-1372.
61. Esler, W.P.; Stimson, E.R.; Ghilardi, J.R.; Felix, A.M.; Lu, Y.A.; Vinters, H.V.; Mantyh, P.W.; Maggio, J.E. Aβ deposition inhibitor screen using synthetic amyloid. Nat. Biotechnol. 1997, 15, 258-263.
62. Nakagami, Y.; Nishimura, S.; Murasugi, T.; Kaneko, I.; Meguro, M.; Marumoto, S.; Kogen, H.; Koyama, K.; Oda, T. A novel β-sheet breaker, RS-0406, reverses amyloid β-induced cytotoxicity and impairment of long-term potentiation in vitro. Br. J. Parmacol. 2002, 137, 676-682.
63. Vitalis, A.; Caflisch, A. Micelle-like architecture of the monomer ensemble of Alzheimer's amyloid-β peptide in aqueous solution and its implications for Aβ aggregation. J. Mol. Biol. 2010, 403, 148-165.
64. Giuffrida, M.L.; Caraci, F.; de Bona, P.; Pappalardo, G.; Nicoletti, F.; Rizzarelli, E.; Copani, A. The monomer state of β-amyloid: Where the Alzheimer's disease protein meets physiology. Rev. Neurosci. 2010, 21, 83-93.
65. Morris, A.M.; Watzky, M.A.; Finke, R.G. Protein aggregation kinetics, mechanism, and curve-fitting: A review of the literature. Biochim. Biophys. Acta 2009, 1794, 375-397.
66. Teplow, D.B. Structural and kinetic features of amyloid β-protein fibrillogenesis. Amyloid 1998, 5, 121-142.
67. Walsh, D.M.; Selkoe, D.J. Aβ oligomers-A decade of discovery. J. Neurochem. 2007, 101, 1172-1184.
68. Alford, B.L.; H�gel, H.M. Total synthesis of (+)-pentamethylsalvianolic acid C. Org. Biomol. Chem. 2013, 11, 2724-2727.
69. Ryan, T.M.; Caine, J.; Mertens, H.D.; Kirby, N.; Nigro, J.; Breheney, K.; Waddington, L.J.; Streltsov, V.A.; Curtain, C.; Masters, C.L.; et al. Ammonium hydroxide treatment of Aβ produces an aggregate free solution suitable for biophysical and cell culture characterization. PeerJ 2013, doi:10.7717/peerj.73.
70. Ryan, T.M.; Friedhuber, A.; Lind, M.; Howlett, G.J.; Masters, C.; Roberts, B.R. Small amphipathic molecules modulate secondary structure and amyloid fibril-forming kinetics of Alzheimer disease peptide Aβ(1-42). J. Biol. Chem. 2012, 287, 16947-16954.
71. De Ferrari, G.V.; Mallender, W.D.; Inestrosa, N.C.; Rosenberry, T.L. Thioflavin T is a fluorescent probe of the acetylcholinesterase peripheral site that reveals conformational interactions between the peripheral and acylation sites. J. Biol. Chem. 2001, 276, 23282-23287.
72. Maezawa, I.; Hong, H.-S.; Liu, R.; Wu, C.-Y.; Cheng, R.H.; Kung, M.-P.; Kung, H.F.; Lam, K.S.; Oddo, S.; LaFerla, F.M.; et al. Congo red and thioflavin-T analogs detect Aβ oligomers. J. Neurochem. 2008, 104, 457-468.
73. Blum, H.; Beier, H.; Gross, H.J. Improved silver staining of plant proteins, RNA and DNA in polyacrylamide gels. Electrophoresis 1987, 8, 93-99.
74. Rabilloud, T.; Vuillard, L.; Gilly, C.; Lawrence, J.J. Silver-staining of proteins in polyacrylamide gels: A general overview. Cell. Mol. Biol. 2009, 40, 57-75.
75. Miles, L.A.; Wun, K.S.; Crespi, G.A.; Fodero-Tavoletti, M.T.; Galatis, D.; Bagley, C.J.; Beyreuther, K.; Masters, C.L.; Cappai, R.; McKinstry, W.J.; et al. Amyloid-β-anti-amyloid-β complex structure reveals an extended conformation in the immunodominant B-cell epitope. J. Mol. Biol. 2008, 377, 181-192.
76. Zhang, J.; Mori, A.; Chen, Q.; Zhao, B. Fermented papaya preparation attenuates β-amyloid precursor protein: β-Amyloid-mediated copper neurotoxicity in β-amyloid precursor protein and β-amyloid precursor protein swedish mutation overexpressing SH-SY5Y cells. Neuroscience 2006, 143, 63-72.
77. Williams, P.; Sorribas, A.; Howes, M.J. Natural products as a source of Alzheimer's drug leads. Nat. Prod. Rep. 2011, 28, 48-77.
78. Ji, H.F.; Zhang, H.Y. Multipotent natural agents to combat Alzheimer's disease. Functional spectrum and structural features. Acta Pharmacol. Sin. 2008, 29, 143-151.
79. Sul, D.; Kim, H.S.; Lee, D.; Joo, S.S.; Hwang, K.W.; Park, S.Y. Protective effect of caffeic acid against beta-amyloid-induced neurotoxicity by the inhibition of calcium influx and tau phosphorylation. Life Sci. 2009, 84, 257-262.
80. Wang, S.-X.; Hu, L.-M.; Gao, X.-M.; Guo, H.; Fan, G.-W. Anti-inflammatory activity of salvianolic acid B in microglia contributes to its neuroprotective effect. Neurochem. Res. 2010, 35, 1029-1037.
81. Zhao, G.R.; Zhang, H.M.; Ye, T.X.; Xiang, Z.J.; Yuan, Y.J.; Guo, Z.X.; Zhao, L.B. Characterization of the radical scavenging and antioxidant activities of danshensu and salvianolic acid B. Food Chem. Toxicol. 2008, 46, 73-81.
82. Porat, Y.; Abramowitz, A.; Gazit, E. Inhibition of amyloid fibril formation by polyphenols: Structural similarity and aromatic interactions as a common inhibition mechanism. Chem. Biol. Drug Des. 2006, 67, 27-37.
83. Mythri, R.B.; Harish, G.; Raghunath, N.; Bharath, M.S. Therapeutic potential of polyphenols in Parkinson's disease. In Towards New Therapies for Parkinson's Disease ; Intech: Rijecka, Croatia, 2011; pp. 115-150.
84. Rice-Evans, C.A.; Miller, N.J.; Paganga, G. Structure-antioxidant activity relationships of flavonoids and phenolic acids. Free Radic. Biol. Med. 1996, 20, 933-956.
85. Dickinson, D.A.; Iles, K.E.; Zhang, H.; Blank, V.; Forman, H.J. Curcumin alters EpRE and AP-1 binding complexes and elevates glutamate-cysteine ligase gene expression. FASEB J. 2003, 17, 473-475.
86. Howlett, D.R.; Perry, A.E.; Godfrey, F.; Swatton, J.E.; Jennings, K.H.; Spitzfaden, C.; Wadsworth, H.; Wood, S.J.; Markwell, R.E. Inhibition of fibril formation in β-amyloid peptide by a novel series of benzofurans. Biochem. J. 1999, 340, 283-289.